Olutasidenib (FT-2102) induces durable complete remissions in patients with relapsed or refractory IDH1-mutated AML
- Resource Type
- Article
- Authors
- de Botton, Stéphane; Fenaux, Pierre; Yee, Karen; Récher, Christian; Wei, Andrew H.; Montesinos, Pau; Taussig, David C.; Pigneux, Arnaud; Braun, Thorsten; Curti, Antonio; Grove, Carolyn; Jonas, Brian A.; Khwaja, Asim; Legrand, Ollivier; Peterlin, Pierre; Arnan, Montserrat; Blum, William; Cilloni, Daniela; Hiwase, Devendra K.; Jurcic, Joseph G.; Krauter, Jürgen; Thomas, Xavier; Watts, Justin M.; Yang, Jay; Polyanskaya, Olga; Brevard, Julie; Sweeney, Jennifer; Barrett, Emma; Cortes, Jorge
- Source
- In Blood Advances 11 July 2023 7(13):3117-3127
- Subject
- Myeloid Neoplasia
Clinical Trials and Observations
- Language
- ISSN
- 2473-9529